Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
1.
Int J Mol Sci ; 20(23)2019 Dec 02.
Article in English | MEDLINE | ID: mdl-31810213

ABSTRACT

Mollusks have served as important sources of human food and medicine for a long time. Raw Pisidium coreanum, a freshwater bivalve of the phylum Mollusca, is used in traditional therapies in parts of Asia. However, the therapeutic effects of Pisidium coreanum on bone diseases are not known. We investigated the functional roles of Pisidium coreanum in osteoporotic bone diseases. Pisidium coreanum inhibited the differentiation of bone marrow-derived monocytic cells into mature osteoclasts in vitro. The ovariectomized mice that received oral administration of Pisidium coreanum showed improvements in both trabecular and cortical bones. This preventive activity of Pisidium coreanum against bone loss was due to limited osteoclast maturation with reduced osteoclast surface extent in trabecular bone tissue. The formation of large multinucleated osteoclasts in vitro was significantly decreased in response to Pisidium coreanum, consistent with the reduced expression levels of osteoclast markers and fusion-related genes, such as NFATc1, p65, integrin αvß3, DC-STAMP, OC-STAMP, Atp6v0d2, FAK, CD44, and MFR. These data suggest that Pisidium coreanum inhibits osteoclast differentiation by negatively regulating the fusion of mononuclear osteoclast precursors. Thus, our data demonstrate the ability of Pisidium coreanum to effectively prevent estrogen-deficient osteoporosis through inhibition of multinucleated osteoclast formation.


Subject(s)
Bivalvia , Bone Diseases/diet therapy , Estrogens/deficiency , Osteoporosis/diet therapy , Animals , Bone Diseases/metabolism , Bone Diseases/physiopathology , Bone Resorption/diet therapy , Bone Resorption/prevention & control , Cell Differentiation/drug effects , Humans , Mice , Osteoclasts/drug effects , Osteoporosis/metabolism , Seafood/analysis
2.
Int J Food Sci Nutr ; 67(7): 754-61, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27338594

ABSTRACT

Western diet, high in protein-rich foods and poor in vegetables, is likely to be responsible for the development of a moderate acid excess leading to metabolism deregulation and the onset or worsening of chronic disturbances. Available findings seem to suggest that diets with high protein/vegetables ratio are likely to induce the development of calcium lithiasis, especially in predisposed subjects. Moreover, some evidence supports the hypothesis of bone metabolism worsening and enhanced bone loss following acid-genic diet consumption although available literature seems to lack direct and conclusive evidence demonstrating pathological bone loss. According to other evidences, diet-induced acidosis is likely to induce or accelerate muscle wasting or sarcopenia, especially among elderlies. Furthermore, recent epidemiological findings highlight a specific role of dietary acid load in glucose metabolism deregulation and insulin resistance. The aim of this review is to investigate the role of acid-genic diets in the development of the mentioned metabolic disorders focusing on the possible clinical improvements exerted by alkali supplementation.


Subject(s)
Acidosis/etiology , Alkalies/administration & dosage , Diet, Western/adverse effects , Dietary Supplements , Bone Diseases/diet therapy , Bone Diseases/etiology , Chronic Disease , Clinical Trials as Topic , Dietary Proteins/administration & dosage , Humans , Insulin Resistance , Sarcopenia/diet therapy , Sarcopenia/etiology , Urinary Calculi/diet therapy , Urinary Calculi/etiology , Vegetables
4.
Nutr Hosp ; 29(2): 370-5, 2014 Feb 01.
Article in English | MEDLINE | ID: mdl-24528355

ABSTRACT

INTRODUCTION: Diabetic patients have a higher risk to osteoporotic fractures. Foods, such as yam, to oppose hyperglycemia, has been used to treatment of diabetes. OBJECTIVE: The goal was assess the role of Brazilian yam (Dioscorea bulbifera) on glycemia and bone parameters of female diabetic rats. METHODS: Female Wistar rats with 3 months age were allocated in three groups. Control group (C, n = 6), treated with normal fat diet. Diabetic rats treated with high-fat diet without (DM, n = 8) and with (DMY, n = 8) liofilized yam flour. After 5 weeks of the experiment, serum glucose and insulin, pancreas mass, number and area of pancreas islets were quantified. And femur parameters were analyzed by dual-energy X-ray absorptiometry (DXA) and computed tomography (CT). RESULTS: Differences were considered significant if P<0.05. Diabetic groups showed lower (P < 0.05): femur and pancreas mass, area of the pancreatic islets and insulin. However, DMY showed lower (-10%, P < 0.05) concentrations of glucose to DM group. Femur, by DXA, showed lower bone mineral density, content and area in the DM group. While the DMY group showed greater (+27%, P < 0.05) radiodensity of femoral head when compared to DM group. DISCUSSION: Brazilian yam flour supplement did not fix a defect, but alleviated the consequences of the experimental diabetic disease. It showed results to control the rise in blood glucose levels in diabetic rats, suggesting protection in oxidative agents and postpone harm in the bone. CONCLUSION: Considering all the findings of the present study, our results suggest that yam flour does act producing benefits in the experimental diabetes.


Introducción: Los pacientes diabéticos tienen un mayor riesgo de fracturas osteoporóticas. Los alimentos, como el ñame, para oponerse a la hiperglucemia, se ha utilizado para el tratamiento de la diabetes. Objetivos: El objetivo era evaluar el papel de ñame brasileño (Dioscorea bulbifera) sobre la glucemia y el hueso parámetros de ratas diabéticas hembra. Métodos: Ratas Wistar hembra con 3 meses de edad fueron asignados en tres grupos. El grupo de control (C, n = 6), tratados con dieta normal de la grasa. Las ratas diabéticas tratadas con dieta alta en grasas y sin (DM, n = 8) y con (DMY, n = 8) harina de ñame liofilizado. Después se cuantificaron 5 semanas del experimento, la glucosa y la insulina en suero, la masa páncreas, el número y el área de islotes del páncreas. Y los parámetros de fémur fueron analizados por absorciometría de rayos X de energía dual (DXA) y la tomografía computarizada (CT). Resultados: Las diferencias se consideraron significativas si P < 0,05. Grupos diabéticos mostraron menor (P < 0,05): el fémur y la masa páncreas, el área de los islotes pancreáticos y la insulina. Sin embargo, DMY mostró inferior (-10%, P < 0,05) concentraciones de glucosa al grupo DM. Fémur, por DXA, mostró menor densidad mineral ósea, el contenido y el área en el grupo de DM. Mientras que el grupo DMY mostró mayor (27%, P < 0,05) radiodensidad de la cabeza femoral en comparación con el grupo de DM. Discusión: Suplemento de harina de ñame brasileña no fijó un defecto, pero alivia las consecuencias de la enfermedad diabética experimental. Se mostró resultados para controlar el aumento de los niveles de glucosa en sangre en ratas diabéticas, lo que sugiere la protección en agentes oxidantes y posponer daño en el hueso. Conclusión: Teniendo en cuenta todos los resultados de este estudio, nuestros resultados sugieren que la harina de ñame actúa de producir beneficios en la diabetes experimental.


Subject(s)
Bone Diseases/diet therapy , Diabetes Mellitus, Experimental/diet therapy , Dioscorea , Hyperglycemia/diet therapy , Animals , Bone Density , Bone Diseases/etiology , Diabetes Mellitus, Experimental/complications , Female , Hyperglycemia/etiology , Rats , Rats, Wistar
5.
J Assoc Physicians India ; 62(7): 572-9, 2014 Jul.
Article in English | MEDLINE | ID: mdl-25672028

ABSTRACT

OBJECTIVES: The objective of this communication is to disseminate scientific and technical information for early diagnosis of Fluorosis; recent developments in care and management of patients of Fluorosis. MATERIAL AND METHODS: Body fluids collected from patients suspected of Fluorosis referred by hospitals, samples of drinking water used by them are the materials that have been investigated. Fluoride level in body fluids and water samples are tested by the ion selective electrode (ISE) potentiometry. Forearm X-ray radiograph is taken to assess interosseous membrane calcification. Upon diagnosis of the disease, two corrective measures, namely diet editing and diet counselling are introduced for practice in daily life. In the former, all sources of fluoride ingestion and use are withdrawn whereas in the latter, the patient is encouraged to consume a diet rich in essential nutrients, antioxidants and micronutrients through fruits, vegetables and dairy products. The patients are monitored at intervals to assess fluoride in body fluids. Reduction in fluoride levels has a direct relationship with disappearance of health complaints and subsequent recovery. RESULTS: Eight case studies (5 male + 3 female) are described. Patients'complaints are gastrointestinal discomfort, polyuria, polydipsia, muscle weakness, fatigue and joint pain. Body fluids may have high fluoride with normal or high fluoride level in drinking water.The main source(s) of fluoride entry identified are (i) consuming fluoride contaminated food/snacks/beverages laced with black rock salt; (ii) drinking of untreated ground water; (iii) using fluoridated toothpaste. The duration of recovery varies from patient to patient depending upon their body physiology and the seriousness with which the interventions were practiced. Recurrence of the disease may occur in some patients due to change in life-style, not practicing interventions, entry of fluoride inadvertently. CONCLUSION: This communication provides an overview of Fluorosis, its occurrence, manifestations, diagnostic tests, results, interventions practiced, monitoring and recovery from the disease.


Subject(s)
Bone Diseases/chemically induced , Developing Countries , Early Diagnosis , Fluorides/adverse effects , Fluorosis, Dental/diagnosis , Gastrointestinal Diseases/chemically induced , Gastrointestinal Diseases/diagnosis , Adult , Bone Diseases/diagnosis , Bone Diseases/diet therapy , Diagnosis, Differential , Feeding Behavior , Female , Fluorides/administration & dosage , Fluorosis, Dental/diet therapy , Gastrointestinal Diseases/diet therapy , Humans , India , Male , Middle Aged
7.
J Environ Public Health ; 2012: 727630, 2012.
Article in English | MEDLINE | ID: mdl-22013455

ABSTRACT

This review looks at the role of an alkaline diet in health. Pubmed was searched looking for articles on pH, potential renal acid loads, bone health, muscle, growth hormone, back pain, vitamin D and chemotherapy. Many books written in the lay literature on the alkaline diet were also reviewed and evaluated in light of the published medical literature. There may be some value in considering an alkaline diet in reducing morbidity and mortality from chronic diseases and further studies are warranted in this area of medicine.


Subject(s)
Diet Therapy , Hydrogen-Ion Concentration , Acidosis/prevention & control , Antineoplastic Agents/pharmacology , Back Pain/diet therapy , Bone Diseases/diet therapy , Bone Diseases/prevention & control , Humans , Minerals , Muscle, Skeletal/physiology , Vitamins
8.
Sports Med ; 41(10): 861-82, 2011 Oct 01.
Article in English | MEDLINE | ID: mdl-21923203

ABSTRACT

Gender-based differences in the physiological response to exercise have been studied extensively for the last four decades, and yet the study of post-exercise, gender-specific recovery has only been developing in more recent years. This review of the literature aims to present the current state of knowledge in this field, focusing on some of the most pertinent aspects of physiological recovery in female athletes and how metabolic, thermoregulatory, or inflammation and repair processes may differ from those observed in male athletes. Scientific investigations on the effect of gender on substrate utilization during exercise have yielded conflicting results. Factors contributing to the lack of agreement between studies include differences in subject dietary or training status, exercise intensity or duration, as well as the variations in ovarian hormone concentrations between different menstrual cycle phases in female subjects, as all are known to affect substrate metabolism during sub-maximal exercise. If greater fatty acid mobilization occurs in females during prolonged exercise compared with males, the inverse is observed during the recovery phase. This could explain why, despite mobilizing lipids to a greater extent than males during exercise, females lose less fat mass than their male counterparts over the course of a physical training programme. Where nutritional strategies are concerned, no difference appears between males and females in their capacity to replenish glycogen stores; optimal timing for carbohydrate intake does not differ between genders, and athletes must consume carbohydrates as soon as possible after exercise in order to maximize glycogen store repletion. While lipid intake should be limited in the immediate post-exercise period in order to favour carbohydrate and protein intake, in the scope of the athlete's general diet, lipid intake should be maintained at an adequate level (30%). This is particularly important for females specializing in long-duration events. With protein balance, it has been shown that a negative nitrogen balance is more often observed in female athletes than in male athletes. It is therefore especially important to ensure that this remains the case during periods of caloric restriction, especially when working with female athletes showing a tendency to limit their caloric intake on a daily basis. In the post-exercise period, females display lower thermolytic capacities than males. Therefore, the use of cooling recovery methods following exercise, such as cold water immersion or the use of a cooling vest, appear particularly beneficial for female athletes. In addition, a greater decrease in arterial blood pressure is observed after exercise in females than in males. Given that the return to homeostasis after a brief intense exercise appears linked to maintaining good venous return, it is conceivable that female athletes would find a greater advantage to active recovery modes than males. This article reviews some of the major gender differences in the metabolic, inflammatory and thermoregulatory response to exercise and its subsequent recovery. Particular attention is given to the identification of which recovery strategies may be the most pertinent to the design of training programmes for athletic females, in order to optimize the physiological adaptations sought for improving performance and maintaining health.


Subject(s)
Athletic Injuries/diet therapy , Exercise/physiology , Nutritional Physiological Phenomena , Recovery of Function , Body Temperature Regulation/physiology , Bone Diseases/diet therapy , Dietary Carbohydrates/metabolism , Dietary Fats/metabolism , Dietary Proteins/metabolism , Dietary Supplements , Female , Humans , Male , Menstrual Cycle/metabolism , Menstrual Cycle/physiology , Muscle Fatigue/physiology , Muscular Diseases/diet therapy , Severity of Illness Index , Sex Factors
9.
Nephrol Nurs J ; 31(3): 333-5, 2004.
Article in English | MEDLINE | ID: mdl-15303430

ABSTRACT

Earlier monitoring and treatment of elevated phosphorus and PTH prior to initiation of dialysis may prevent the development of bone disease. We can no longer be complacent or content with patients having a calcium-phosphorus product of 70 or phosphorus of 6.0. When we strive for the recommended optimal levels and goals and work toward these new goals we will improve our patient outcomes. We must be vigilant and have an increased intensity of focus on bone metabolism as part of the total patient care. The entire team serves to provide ongoing education and encouragement throughout the continuum of care with the CKD client.


Subject(s)
Bone and Bones/metabolism , Kidney Diseases/metabolism , Kidney Diseases/nursing , Nephrology/standards , Nutrition Therapy/standards , Practice Guidelines as Topic , Specialties, Nursing/standards , Bone Diseases/diet therapy , Bone Diseases/nursing , Bone Diseases/prevention & control , Calcium/analysis , Calcium/metabolism , Calcium/therapeutic use , Chronic Disease , Humans , Kidney Diseases/diet therapy , Nephrology/methods , Nutrition Therapy/methods , Nutrition Therapy/nursing , Parathyroid Hormone/analysis , Parathyroid Hormone/metabolism , Parathyroid Hormone/therapeutic use , Phosphorus/analysis , Phosphorus/metabolism , Phosphorus/therapeutic use , Renal Dialysis/nursing , Specialties, Nursing/methods , Vitamin D/therapeutic use
11.
BMC Musculoskelet Disord ; 4: 2, 2003 Feb 20.
Article in English | MEDLINE | ID: mdl-12597778

ABSTRACT

BACKGROUND: Classical homocystinuria is an autosomal recessive disorder caused by cystathionine beta-synthase (CBS) deficiency and characterized by distinctive alterations of bone growth and skeletal development. Skeletal changes include a reduction in bone density, making it a potentially attractive model for the study of idiopathic osteoporosis. METHODS: To investigate this aspect of hyperhomocysteinemia, we supplemented developing chicks (n = 8) with 0.6% dl-homocysteine (hCySH) for the first 8 weeks of life in comparison to controls (n = 10), and studied biochemical, biomechanical and morphologic effects of this nutritional intervention. RESULTS: hCySH-fed animals grew faster and had longer tibiae at the end of the study. Plasma levels of hCySH, methionine, cystathionine, and inorganic sulfate were higher, but calcium, phosphate, and other indices of osteoblast metabolism were not different. Radiographs of the lower limbs showed generalized osteopenia and accelerated epiphyseal ossification with distinct metaphyseal and suprametaphyseal lucencies similar to those found in human homocystinurics. Although biomechanical testing of the tibiae, including maximal load to failure and bone stiffness, indicated stronger bone, strength was proportional to the increased length and cortical thickness in the hCySH-supplemented group. Bone ash weights and IR-spectroscopy of cortical bone showed no difference in mineral content, but there were higher Ca2+/PO4(3-) and lower Ca2+/CO3(2-) molar ratios than in controls. Mineral crystallization was unchanged. CONCLUSION: In this chick model, hyperhomocysteinemia causes greater radial and longitudinal bone growth, despite normal indices of bone formation. Although there is also evidence for an abnormal matrix and altered bone composition, our finding of normal biomechanical bone strength, once corrected for altered morphometry, suggests that any increase in the risk of long bone fracture in human hyperhomocysteinemic disease is small. We also conclude that the hCySH-supplemented chick is a promising model for study of the connective tissue abnormalities associated with homocystinuria and an important alternative model to the CBS knock-out mouse.


Subject(s)
Bone Diseases/blood , Bone Diseases/diet therapy , Bone and Bones/chemistry , Disease Models, Animal , Hyperhomocysteinemia , Animals , Blood Chemical Analysis , Bone Density/physiology , Bone Development/physiology , Bone Diseases/diagnostic imaging , Bone Matrix/chemistry , Bone Matrix/growth & development , Bone Matrix/physiopathology , Bone and Bones/diagnostic imaging , Bone and Bones/physiopathology , Chickens , Diet/methods , Homocysteine/metabolism , Hyperhomocysteinemia/diagnostic imaging , Hyperhomocysteinemia/diet therapy , Hyperhomocysteinemia/metabolism , Hyperhomocysteinemia/physiopathology , Radiography , Tibia/chemistry , Tibia/diagnostic imaging , Tibia/growth & development , Tibia/physiopathology
12.
Exp Biol Med (Maywood) ; 226(6): 485-97, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11395919

ABSTRACT

This minireview on skeletal biology describes the actions of prostaglandins and cytokines involved in the local regulation of bone metabolism, it documents the role of lipids in bone biology, and it presents relationships between fatty acids and other factors that impact skeletal metabolism. The data presented herein show consistent and reproducible beneficial effects of omega-3 (n-3) fatty acids on bone metabolism and bone/joint diseases. Polyunsaturated fatty acids modulate eicosanoid biosynthesis in numerous tissues and cell types, alter signal transduction, and influence gene expression. These effects have not been explored in the skeletal system. Future research on n-3 fatty acids in bone biology should focus on the following two aspects. First, the further elucidation of how n-3 fatty acids alter biochemical and molecular processes involved in bone modeling and bone cell differentiation, and second, the evaluation of the potential pharmaceutical applications of these nutraceutical fatty acids in maintaining bone mineral status and controlling inflammatory bone/joint diseases.


Subject(s)
Bone Diseases/drug therapy , Bone and Bones/drug effects , Fatty Acids, Omega-3/pharmacology , Isoflavones , Animals , Bone Diseases/diet therapy , Bone Diseases/metabolism , Bone and Bones/metabolism , Estrogens, Non-Steroidal/metabolism , Fatty Acids, Omega-3/metabolism , Flavonoids/metabolism , Health Status , Humans , Phytoestrogens , Plant Preparations
13.
Kidney Int ; 58(3): 1023-32, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10972667

ABSTRACT

BACKGROUND: Hyperphosphatemia and metabolic acidosis are general features of advanced chronic renal failure (RF), and each may affect mineral metabolism. The goal of the present study was to evaluate the effect of chronic metabolic acidosis on the development of hyperparathyroidism and bone disease in normal and azotemic rats on a high-phosphate diet. Our assumption that the two groups of azotemic rats (acid-loaded vs. non-acid-loaded) would have the same degree of renal failure at the end of the study proved to be incorrect. METHODS: Four groups of rats receiving a high-phosphate (1.2%), normal-calcium (0.6%) diet for 30 days were studied: (1) normal (N); (2) normal + acid (N + Ac) in which 1.5% ammonium chloride (NH4Cl) was added to the drinking water to induce acidosis; (3) RF, 5/6 nephrectomized rats; and (4) RF + acid (RF + Ac) in which 0.75% NH4Cl was added to the drinking water of 5/6 nephrectomized rats to induce acidosis. RESULTS: At sacrifice, the arterial pH and serum bicarbonate were lowest in the RF + Ac group and were intermediate in the N + Ac group. Serum creatinine (0.76 +/- 0.08 vs. 1.15 +/- 0.08 mg/dL), blood urea nitrogen (52 +/- 8 vs. 86 +/- 13 mg/dL), parathyroid hormone (PTH; 180 +/- 50 vs. 484 +/- 51 pg/mL), and serum phosphate (7.46 +/- 0.60 vs. 12.87 +/- 1.4 mg/dL) values were less (P < 0.05), and serum calcium (9.00 +/- 0.28 vs. 7.75 +/- 0.28 mg/dL) values were greater (P < 0.05) in the RF + Ac group than in the RF group. The fractional excretion of phosphate (FEP) was greater (P < 0.05) in the two azotemic groups than in the two nonazotemic groups. In the azotemic groups, the FEP was similar even though PTH and serum phosphate values were less in the RF + Ac than in the RF group. NH4Cl-induced acidosis produced hypercalciuria in the N + Ac and RF + Ac groups. When acid-loaded (N + Ac and RF + Ac) and non-acid-loaded (N and RF) rats were combined as separate groups, serum phosphate and PTH values were less for a similarly elevated serum creatinine value in acid-loaded than in non-acid-loaded rats. Finally, the osteoblast surface was less in the N + Ac group than in the other groups. However, in the acid-loaded azotemic group (RF + Ac), the osteoblast surface was not reduced. CONCLUSIONS: The presence of chronic metabolic acidosis in 5/6 nephrectomized rats on a high-phosphate diet (1) protected against the progression of RF, (2) enhanced the renal clearance of phosphate, (3) resulted in a lesser degree of hyperparathyroidism, and (4) did not reduce the osteoblast surface. The combination of metabolic acidosis and phosphate loading may protect against the progression of RF and possibly bone disease because the harmful effects of acidosis and phosphate loading may be counterbalanced.


Subject(s)
Acidosis/diet therapy , Kidney Failure, Chronic/diet therapy , Phosphates/pharmacology , Phosphorus, Dietary/pharmacology , Uremia/diet therapy , Animals , Blood Gas Analysis , Body Weight , Bone Diseases/diet therapy , Bone Diseases/metabolism , Calcium/blood , Calcium/urine , Chronic Disease , Creatinine/blood , Creatinine/urine , Diet , Disease Progression , Hyperparathyroidism, Secondary/diet therapy , Hyperparathyroidism, Secondary/metabolism , Kidney Failure, Chronic/metabolism , Male , Minerals/metabolism , Nephrectomy , Parathyroid Hormone/blood , Phosphates/blood , Phosphates/urine , Phosphorus, Dietary/blood , Phosphorus, Dietary/urine , Rats , Rats, Wistar , Uremia/metabolism
14.
Toxicology ; 133(2-3): 93-103, 1999 Apr 15.
Article in English | MEDLINE | ID: mdl-10378476

ABSTRACT

Exposure to cadmium (Cd) can result in nephrotoxicity and osteotoxicity. Because Cd-induced nephrotoxicity involves oxidative stress and caloric restriction decreases oxidative stress, we examined whether reduced caloric intake will protect against Cd-induced nephrotoxicity. In addition, the protection against the osteotoxicity was also examined. Male and female Sprague-Dawley rats were provided drinking water containing 100 mg Cd/l. Since fluid intake relative to the body weight was higher in females as compared to the males, the Cd concentration in their water was reduced to 80 mg/l after 3 months and 65 mg/l after 6.5 months. During the 27 month exposure period the males and females consumed a total of about 5 g Cd/kg body weight. Food was restricted to 20 g/day after the first 3 months. During the unrestricted food intake period Cd exposure reduced the bone density in females by 23%, with a partial recovery and stabilization during the caloric restriction phase. Hepatic and renal Cd accumulation and corresponding metallothionein (MT) levels were very similar in both sexes. The reported critical Cd concentration for nephrotoxicity was reached by 9 months. Renal MT levels were maximum at this time. Despite a 1.5-fold increase in renal Cd concentration over the next 18 months, there was no significant increase in renal MT levels. In spite of high renal Cd levels and lack of availability of sufficient MT, there was no sign of nephrotoxicity, as measured by urinary protein and glucose excretion. It is concluded that caloric restriction prevents Cd-induced nephrotoxicity and also appears to control the osteotoxicity of Cd.


Subject(s)
Cadmium/toxicity , Energy Intake , Animals , Body Weight/physiology , Bone Density/drug effects , Bone Density/physiology , Bone Diseases/chemically induced , Bone Diseases/diet therapy , Bone Diseases/prevention & control , Cadmium/pharmacokinetics , Drinking , Female , Kidney/drug effects , Kidney/metabolism , Kidney Diseases/chemically induced , Kidney Diseases/diet therapy , Kidney Diseases/prevention & control , Liver/metabolism , Male , Metallothionein/metabolism , Rats , Rats, Sprague-Dawley , Sex Factors
15.
Z Gesamte Inn Med ; 44(17): 509-12, 1989 Sep 01.
Article in German | MEDLINE | ID: mdl-2588720

ABSTRACT

In 158 inpatients (61 m., 97 f.) with obesity-associated diseases were performed a diet-training-programme for about four weeks. We used a PSMF (protein sparing modified fasting) as a 350 kcal diabetic mixed diet, adequate to 4 carbohydrate units (40g carbohydrate, 30g protein, 5g fat) with weekly tea-vegetable-days, additionally wheat brain. The training programme was adapted individually. Reexamination were made by questionnaires and diabetic control cards concerning the body weight. The favourable influence of blood pressure and metabolism was registered. The diet schedule consist natural foodstuffs, fibers, minerals and vitamins. It can be varied, is very effective especially in combination with exercise. The middle term results are rather good more for women than men. Our diet-training-programme can be recommended for outpatients as well as for cures.


Subject(s)
Diet, Reducing , Exercise , Obesity/diet therapy , Bone Diseases/diet therapy , Cardiovascular Diseases/diet therapy , Combined Modality Therapy , Diabetes Mellitus, Type 2/diet therapy , Diet, Diabetic , Fasting , Follow-Up Studies , Humans , Male , Middle Aged , Obesity/complications
16.
J Dairy Sci ; 64(2): 217-26, 1981 Feb.
Article in English | MEDLINE | ID: mdl-7276309

ABSTRACT

Our objective was to characterize changes in vitamin D metabolites of plasma in Jersey cows fed a prepartum low-calcium diet. Eight cows were fed a high-calcium diet (80 g/day) and eight were fed a low-calcium diet (8 g/day) at least 14 days before parturition. Calcium concentrations in plasma decreased after initiation of feeding either diet, but cows fed low-calcium diet tended to have lower prepartum calcium and phosphorus and greater peripartal calcium in plasma. Hydroxyproline in plasma was greater during peripartal period in cows fed low-calcium diet. Prepartum 1,25-dihydroxyvitamin D in plasma tended to be greater in cows fed low calcium. Increases in 1,25-dihydroxyvitamin D were only 2 and 3 days after initiation of the low-calcium diet; during the first 2 days after parturition, however, 1,25-dihydroxyvitamin D tended to be lower in those cows fed low calcium. As parturition neared, 24,25-dihydroxyvitamin D tended to be lower in cows fed the low calcium-diet. Usual early postpartum changes in calcium phosphorus, magnesium, 1,25-dihydroxyvitamin D, and hydroxyproline were seen during first few days after initiation of feeding low calcium. Thus, we propose that the preventative action of the low-calcium diet is associated with preparation of the calcium homeostatic mechanism several days before the calcium demand of initiation of lactation.


Subject(s)
Calcium, Dietary/therapeutic use , Cattle Diseases/prevention & control , Dihydroxycholecalciferols/blood , Hydroxycholecalciferols/blood , Hypocalcemia/veterinary , Animals , Bone Diseases/diet therapy , Bone Diseases/prevention & control , Bone Diseases/veterinary , Calcium/blood , Cattle , Cattle Diseases/diet therapy , Female , Hydroxyproline/blood , Hypocalcemia/diet therapy , Hypocalcemia/prevention & control , Labor, Obstetric , Obstetric Labor Complications/prevention & control , Obstetric Labor Complications/veterinary , Phosphorus/blood , Pregnancy
17.
J Pediatr ; 96(3 Pt 2): 528-34, 1980 Mar.
Article in English | MEDLINE | ID: mdl-7359255

ABSTRACT

By photon absorptiometry, extrauterine bone mineralization in low-birth-weight infants fed a standard commercial formula lags significantly behind intrauterine bone mineralization. In the present study, infants of 28- to 32-week and 33- to 35-week gestational age were studied. The calcium content in a standard formula was increased to provide a daily calcium intake of 220 to 250 mg/kg/day. Phosphate intake was 110 to 125 mg/kg/day. Extrauterine bone mineralization by photon absorptiometry appeared to approximate the intrauterine bone mineralization rate.


Subject(s)
Bone Diseases/diet therapy , Calcium, Dietary/administration & dosage , Infant, Premature, Diseases/diet therapy , Bone Diseases/etiology , Bone Diseases/metabolism , Calcification, Physiologic , Calcium/metabolism , Humans , Infant Nutritional Physiological Phenomena , Infant, Newborn , Infant, Premature, Diseases/etiology , Infant, Premature, Diseases/metabolism , Phosphorus/administration & dosage , Phosphorus/metabolism , Vitamin D/administration & dosage , Vitamin D/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...